Source: Annual Congress 2011 - Physiological basis of respiratory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. A. Rodriguez, J. Roca, A. Ramirez-Sarmiento, I. Blanco, J. Gea, A. Barberan, Y. Torralba, A. Arbillaga, J. A. Barbera, J. Vilaro, M. Orozco-Levi (Barcelona, Spain). Iron deficiency as a novel biomarker of functional impairment in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 2011; 38: Suppl. 55, 4740

Member's Comments

No comment yet.

Related content which might interest you: Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 Early peripheral muscle structural and metabolic impairment in chronic obstructive pulmonary disease (COPD) patients cannot be considered as a consequence of sedentarity Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers Year: 2011 Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2011 - COPD management Year: 2011 The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007 Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Desmosin as a marker for tissue injury in COPD Source: Annual Congress 2007 - α1-Antitrypsin deficiency: molecular and clinical news Year: 2007 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 An early prediction of intravascular microthromb formation for patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Candidate gene associations in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - The biology of smoking and COPD Year: 2008 Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Prevalence of vitamin D deficiency in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Predictive factors of endothelial function in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Prediction of vascular-platelet hemostasis disorders in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 Frequency distribution of the novel GOLD-stages in newly diagnosed chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 348s Year: 2001 Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008